After the knockdown of PRAME, the proliferation of both PC9 and A549 cells was significantly increased starting at 3 days after transfection as evidenced by MTT assay, suggesting that PRAME inhibits lung cancer cell proliferation (Fig 1C). This evidence concerns the gene PRAME and lung cancer.